Journals / Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi / 2000 / Cilt: 1 - Sayı: 2

Efficacy of prophylaxis with norfloxacin in transrectal prostate biopsy

Transrektal prostat biyopsisi uygulanan hastalarda norfloksasin ile profilaksi etkinliği

Pages
5–7
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Norfloxacin prophylaxis for 1 week effectively minimizes such complications and it also has a low cost.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Transrectal needle biopsy is the standard method in the diagnosis of prostate cancer.
📊
Key Findings & Data:Methods: Thirty-four patients undergoing transrectal biopsies of the prostate received 400 mg of norfloxacin twice a day starting 24 h before biopsy and continued for 1 week.
💡
Conclusion & Impact:Norfloxacin prophylaxis for 1 week effectively minimizes such complications and it also has a low cost.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Transrectal needle biopsy is the standard method in the diagnosis of prostate cancer. Various antibiotic regimens have been used to reduce the complication of infection associated with this procedure. However, there is no well-established antibiotic regimen for patients undergoing transrectal biopsy of the prostate. Methods: Thirty-four patients undergoing transrectal biopsies of the prostate received 400 mg of norfloxacin twice a day starting 24 h before biopsy and continued for 1 week. In 48 hours and 7th day after transrectal needle biopsy were provided urine culture. Significant bacteriuria was defined as more than 1x105 colony / mL and febrile attack was accepted as high fever reaching 38.5°C. Results: Each rates of bacteraemia and urinary tract infection were 3%, and no patient developed sepsis. Discussion: The development of infection after transrectal biopsy of prostate is not rare. With the purpose of preventing such complications, intravenous antibiotics in high cost are commonly used. Norfloxacin prophylaxis for 1 week effectively minimizes such complications and it also has a low cost.

Özet

Amaç: Transrektal iğne biyopsisi (TRİB) günümüzde prostat kanseri tanısı için standart tanı yöntemidir. Bu işleme bağlı enfektif komplikasyonların olasılığını azaltmak için çeşitli antibiyotik rejimleri kullanılmaktadır. Ancak TRİB profilaksisinde standart bir profilaksi rejimi henüz mevcut değildir. Yöntem: Kliniğimizde TRİB uygulanan 34 olguya işlemden 24 saat önce başlanarak ve 2x400 mg/gün dozunda 1 hafta süreyle norfloksasin profilaksisi uygulandı. TRİB sonrasındaki 48. saat ve 7. günde olmak üzere hastaların tümünden iki kez idrar kültürü alındı. Bakteriüri >1x105 koloni / ml olarak, febril atak >38.5 C'ye ulaşan ateş olarak kabul edildi. Bulgular: Febril enfeksiyon oranı %3 ve üriner enfeksiyon oranı %3 olarak kaydedilirken, sepsis olgusuna rastlanmadı. Sonuç: TRİB sonrası görülebilecek enfeksiyon komplikasyon oranı küçümsenmeyecek derecededir. Bu gibi enfektif komplikasyonları engellemek amacıyla değişik maliyette ve genellikle parenteral antibiyotik içeren profilaksi rejimleri kullanılmaktadır. Norfloksasin ile işlemden 24 saat önce başlanan ve 1 hafta uygulanan profilaksi bu tip komplikasyonları minimale indirmesi ve düşük maliyeti ile TRİB profilaksisi için iyi bir aday olmaktadır.

🔖

Cite This Article

EYİGÖR, M., EROL, H., KOÇAK, İ., ÖGE, Ö., GEMALMAZ, H., ÖZEREN, B. (2022). Efficacy of prophylaxis with norfloxacin in transrectal prostate biopsy. Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi, Cilt: 1 - Sayı: 2, 5–7. https://ajindex.com/articles/429160

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Clements R. The changing role of transrektal ultrasound in the diagnosis of prostate cancer. Clin Radiol 1996; 51: 671-6. 2.Bissada NK, Rountree GA, Sulieman JS. Factors affecting accuracy and morbidity in transrectal biopsy of the prostate. Surg Gyn Obs 1977; 145: 869-72. 3.Crawford ED, Haynes AL, Story MW, Borden TA. Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy. Br J Urol 1982; 127: 449-51. 4.Davison P, Malament M. Urinary contamination as a result of transrectal biopsy of the prostate. J Urol 1971; 105: 545-6. 5.Ruebush TK, McConville JH, Calia FM. A doubleblind study of trimetoprim-sulfamethoxazole prophylaxis in patients having transrectal biopsy of the prostate. J Urol 1979; 122: 492-4. 6.Dowlen LW, Black NL, Politano VA. Complications of transrectal biopsy examination of the prostate. S M J 1974; 67:.1453-7. 7.Thompson PM, Talbot RW, Packham DA and Dulake C. Transrectal biopsy of the prostate and bacteraemia. Br J Surg 1980; 67: 127-31. 8.Taylor H M, Bingham JB. Antibiotic prophylaxis for transrectal prostate biopsy. J Antimic Chem 1997; 39:115-7. 9.Fawcett DP, Eykyn S, Bultitude MI. Urinary tract infection following trans-rectal biopsy of the prostate. Br J Urol 1975; 47: 679-81. 10.Rodriguez LV, Terris MK. Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and the review of the literature. J Urol 1998; 160: 2115-20. 11.Cooner WH, Mosley BR, Rutherford CL, Beard JH, Pond HS, Terry WJ, Igel TC, Kidd DD. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 1990; 143: 1146-9. 12.Aus G, Hermansson CG, Hugosson J and Pedersen KV. Transrectal ultrasound examination of the prostate: complications and acceptance by patients. Br J Urol 1993; 71: 460-3. 13.Sieber PR, Rommel FM, Agusta VE, Breslin JA,Huffnagle HW, Harpster LE. Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy. J Urol. 1997; 157: 2199-202. 14.Aus G, Ahlgren G, Bergdahl S, et al. Infection after transrectal core biopsies of the prostate: risk factors and antibiotic prophylaxis. Br J Urol 1996; 77: 851-5.